88 related articles for article (PubMed ID: 20421714)
1. p27Kip1 is needed...for glioma invasion.
Concha C; Besson A
Cell Cycle; 2010 Apr; 9(8):1457. PubMed ID: 20421714
[No Abstract] [Full Text] [Related]
2. p27 deficiency is associated with migration defects in PDGF-expressing gliomas in vivo.
See WL; Heinberg AR; Holland EC; Resh MD
Cell Cycle; 2010 Apr; 9(8):1562-7. PubMed ID: 20404478
[TBL] [Abstract][Full Text] [Related]
3. LIM domain only 2 induces glioma invasion via cytosolic p27(KIP1).
Park CG; Sohn YW; Kim EJ; Kim SH; Kim SC; Kim H
Tumour Biol; 2016 Feb; 37(2):2473-80. PubMed ID: 26383528
[TBL] [Abstract][Full Text] [Related]
4. The suppressive effect of Rho kinase inhibitor, Y-27632, on oncogenic Ras/RhoA induced invasion/migration of human bladder cancer TSGH cells.
Chang HR; Huang HP; Kao YL; Chen SL; Wu SW; Hung TW; Lian JD; Wang CJ
Chem Biol Interact; 2010 Jan; 183(1):172-80. PubMed ID: 19896475
[TBL] [Abstract][Full Text] [Related]
5. SHROOM2 inhibits tumor metastasis through RhoA-ROCK pathway-dependent and -independent mechanisms in nasopharyngeal carcinoma.
Yuan J; Chen L; Xiao J; Qi XK; Zhang J; Li X; Wang Z; Lian YF; Xiang T; Zhang Y; Chen MY; Bei JX; Zeng YX; Feng L
Cell Death Dis; 2019 Jan; 10(2):58. PubMed ID: 30683844
[TBL] [Abstract][Full Text] [Related]
6. TM4SF5 accelerates G1/S phase progression via cytosolic p27Kip1 expression and RhoA activity.
Kim H; Kang M; Lee SA; Kwak TK; Jung O; Lee HJ; Kim SH; Lee JW
Biochim Biophys Acta; 2010 Aug; 1803(8):975-82. PubMed ID: 20399237
[TBL] [Abstract][Full Text] [Related]
7. Spatio-temporal co-ordination of RhoA, Rac1 and Cdc42 activation during prototypical edge protrusion and retraction dynamics.
Martin K; Reimann A; Fritz RD; Ryu H; Jeon NL; Pertz O
Sci Rep; 2016 Feb; 6():21901. PubMed ID: 26912264
[TBL] [Abstract][Full Text] [Related]
8. On the move: p27Kip1 drives cell motility in glioma cells.
Bhatia B
Cell Cycle; 2010 Apr; 9(7):1231-40. PubMed ID: 20404527
[No Abstract] [Full Text] [Related]
9. Roles of Rho guanosine 5'-triphosphatase A, Rho kinases, and extracellular signal regulated kinase (1/2) in prostaglandin E2-mediated migration of first-trimester human extravillous trophoblast.
Nicola C; Chirpac A; Lala PK; Chakraborty C
Endocrinology; 2008 Mar; 149(3):1243-51. PubMed ID: 18079197
[TBL] [Abstract][Full Text] [Related]
10. The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway.
Laezza C; Pisanti S; Malfitano AM; Bifulco M
Endocr Relat Cancer; 2008 Dec; 15(4):965-74. PubMed ID: 18676619
[TBL] [Abstract][Full Text] [Related]
11. Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA.
Tabu K; Ohba Y; Suzuki T; Makino Y; Kimura T; Ohnishi A; Sakai M; Watanabe T; Tanaka S; Sawa H
Mol Cancer Res; 2007 Oct; 5(10):1099-109. PubMed ID: 17951409
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells.
Xu XT; Song QB; Yao Y; Ruan P; Tao ZZ
Hepatogastroenterology; 2012; 59(120):2523-6. PubMed ID: 22584506
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cell migration by mTOR is mediated through changes in p27Kip1 phosphorylation.
Woods TC
Cell Cycle; 2010 Jun; 9(11):2057-8. PubMed ID: 20505330
[No Abstract] [Full Text] [Related]
15. Trapidil inhibits platelet-derived growth factor-induced migration via protein kinase A and RhoA/Rho-associated kinase in rat vascular smooth muscle cells.
Ishikura K; Fujita H; Hida M; Awazu M
Eur J Pharmacol; 2005 May; 515(1-3):28-33. PubMed ID: 15894306
[TBL] [Abstract][Full Text] [Related]
16. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.
Zohrabian VM; Forzani B; Chau Z; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2009 Jan; 29(1):119-23. PubMed ID: 19331140
[TBL] [Abstract][Full Text] [Related]
17. Expression of RhoA mRNA and activated RhoA in urothelium and smooth muscle, and effects of a Rho-kinase inhibitor on contraction of the porcine urinary bladder.
Nakanishi K; Kamai T; Mizuno T; Arai K; Yamanishi T
Neurourol Urodyn; 2009; 28(6):521-8. PubMed ID: 19214992
[TBL] [Abstract][Full Text] [Related]
18. Vincristine promotes migration and invasion of colorectal cancer HCT116 cells through RhoA/ROCK/ Myosin light chain pathway.
Jin X; Liu K; Jiao B; Wang X; Huang S; Ren W; Zhao K
Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):91-96. PubMed ID: 27894406
[TBL] [Abstract][Full Text] [Related]
19. Rho/ROCK pathway inhibition by the CDK inhibitor p27(kip1) participates in the onset of macrophage 3D-mesenchymal migration.
Gui P; Labrousse A; Van Goethem E; Besson A; Maridonneau-Parini I; Le Cabec V
J Cell Sci; 2014 Sep; 127(Pt 18):4009-23. PubMed ID: 25015295
[TBL] [Abstract][Full Text] [Related]
20. Stopping and going with p27kip1.
Assoian RK
Dev Cell; 2004 Apr; 6(4):458-9. PubMed ID: 15068785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]